NASDAQ
Angion Biomedica Corp. (ANGN) has a free cash flow growth of -70.92% as of Friday, May 29, 2026. This represents a 543.71% decrease compared to its 12-month average of 15.98%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.